Phase 1 Trial Begins Evaluating Safety of Focused Ultrasound in Alzheimer’s Patients
$1.7 Million NIH Grant to Fund Pain Therapeutics’ Study of PTI-125 as Candidate for Alzheimer’s Treatment
June 7, 2017Cognitive Tests May Help Detect Early Alzheimer’s in Patients Without Symptoms
June 7, 2017
Insightec’s new platform, Exablate Neuro, is to be a part of the first-ever clinical trial (NCT02986932) evaluating the safety and feasibility of opening the blood-brain barrier (BBB) in Alzheimer’s disease patients at Sunnybrook Health Sciences Centre in Toronto, Canada.
